Urine Aquaporin-2 Level is a Novel Marker for the Better Prognosis After Long-Term Tolvaptan Treatment in Patients With Advanced Heart Failure

被引：0
|
作者：
Imamura, Teruhiko
Kinugawa, Koichiro
Fujino, Takeo
Inaba, Toshiro
Maki, Hisataka
Hatano, Maasaru
Yao, Atsushi
Komuro, Issei
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diuretics; Kidney; Vasopressins;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
9411
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Significance of novel biomarkers for short-term and long-term prognosis in patients after acute heart failure decompensation
    Protasov, V. N.
    Skvortsov, A. A.
    Narusov, O. Y.
    Protasova, D. E.
    Kuznetcova, T. V.
    Tkachev, G. A.
    Masenko, V. P.
    Tereshchenko, S. N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 241 - 241
  • [12] Prognostic factors for long-term outcomes in acute decompensated heart failure patients under tolvaptan treatment
    Koichiro Matsumura
    Shun Morishita
    Naoki Taniguchi
    Kazuya Takehana
    Hiroki Takahashi
    Munemitsu Otagaki
    Kei Yoshioka
    Yoshihiro Yamamoto
    Masahiko Takagi
    Ichiro Shiojima
    Heart and Vessels, 2019, 34 : 607 - 615
  • [13] Effect of Long-term Treatment of Tolvaptan in Patients with Acute Decompensated Heart Failure and Chronic Kidney Disease
    Uemura, Yusuke
    Imai, Ryo
    Miura, Ayako
    Mitsuda, Takayuki
    Ishikawa, Shinji
    Koyasu, Masayoshi
    Uchikawa, Tomohiro
    Takemoto, Kenji
    Watarai, Masato
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S181 - S181
  • [14] LONG-TERM PROGNOSIS OF PATIENTS WITH CONGESTIVE HEART-FAILURE
    MATOBA, M
    MATSUI, S
    HIRAKAWA, T
    AOYAMA, T
    TAKEDA, F
    ASAJI, T
    DOYOUSITA, H
    ENYAMA, H
    FUKUOKA, T
    NAKATOU, H
    EMOTO, J
    TAKEKOSHI, N
    MURAKAMI, E
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1990, 54 (01): : 57 - 61
  • [15] Impact of Implantable Ventricular Assist Devices on Long-term Prognosis of Patients with Advanced Heart Failure
    Aoki, Tatsuo
    Sugimura, Koichiro
    Nochioka, Kotaro
    Tatebe, Shunsuke
    Yamamoto, Saori
    Miura, Masanobu
    Sato, Kimio
    Akiyama, Masatoshi
    Saiki, Yoshikatsu
    Shimokawa, Hiroaki
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S203 - S204
  • [16] Long-term Effect of Tolvaptan in "Super-aged" Patients with Chronic Heart Failure
    Koyama, Toru
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S159 - S160
  • [17] Renoprotection by long-term low-dose tolvaptan in patients with heart failure and hyponatremia
    Oka, Tatsufumi
    Hamano, Takayuki
    Ohtani, Tomohito
    Doi, Yohei
    Shimada, Karin
    Matsumoto, Ayumi
    Yamaguchi, Satoshi
    Hashimoto, Nobuhiro
    Senda, Masamitsu
    Sakaguchi, Yusuke
    Matsui, Isao
    Nakamoto, Kei
    Sera, Fusako
    Hikoso, Shungo
    Sakata, Yasushi
    Isaka, Yoshitaka
    ESC HEART FAILURE, 2021, 8 (06): : 4904 - 4914
  • [18] Renoprotection by long-term low-dose tolvaptan in patients with heart failure and hyponatremia
    Oka, Tatsufumi
    Hamano, Takayuki
    Ohtani, Tomohito
    Doi, Yohei
    Shimada, Karin
    Matsumoto, Ayumi
    Yamaguchi, Satoshi
    Hashimoto, Nobuhiro
    Senda, Masamitsu
    Sakaguchi, Yusuke
    Matsui, Isao
    Nakamoto, Kei
    Sera, Fusako
    Hikoso, Shungo
    Sakata, Yasushi
    Isaka, Yoshitaka
    ESC HEART FAILURE, 2022, 8 (06): : 4904 - 4914
  • [19] Serum parathyroid hormone level is a marker for worse prognosis in patients with advanced heart failure
    Wisniewska, J.
    Drohomirecka, A.
    Sohieszczanska-Malek, M.
    Zielinski, T.
    EUROPEAN HEART JOURNAL, 2017, 38 : 510 - 510
  • [20] Procalcitonin and long-term prognosis after an admission for acute heart failure
    Pilar Villanueva, Maria
    Mollar, Anna
    Palau, Patricia
    Carratala, Arturo
    Nunez, Eduardo
    Santas, Enrique
    Bodi, Vicent
    Chorro, Francisco J.
    Minana, Gema
    Blasco, Maria L.
    Sanchis, Juan
    Nunez, Julio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (01) : 42 - 48
12345